Paper17823767
Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.
Speiser Z and 5 others. J Neural Transm (Vienna), 2008. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline. Papers, record 17823767. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17823767
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fluoxetine | Major topic |
| Monoamine Oxidase Inhibitors | Major topic |
| Serotonin Syndrome | Major topic |
| Selective Serotonin Reuptake Inhibitors | Major topic |
| Animals | |
| Behavior, Animal | |
| Brain | |
| Drug Therapy, Combination | |
| Indans | |
| Male | |
| Methamphetamine | |
| Rats | |
| Rats, Sprague-Dawley | |
| Selegiline |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1203627 | Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration. | Br J Pharmacol | 1975 | https://conductscience.org/library/papers/1203627 | PubMed |
| 2 | 16256213 | Mice over-expressing the 5-HT(1A) receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT. | Behav Brain Res | 2006 | https://conductscience.org/library/papers/16256213 | PubMed |
| 3 | 11164765 | Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. | Brain Res | 2001 | https://conductscience.org/library/papers/11164765 | PubMed |
| 4 | 708990 | The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats. | Br J Pharmacol | 1978 | https://conductscience.org/library/papers/708990 | PubMed |
| 5 | 12873279 | Serotonin syndrome and other serotonergic disorders. | Pain Med | 2003 | https://conductscience.org/library/papers/12873279 | PubMed |
| 6 | 12603236 | Death following ingestion of MDMA (ecstasy) and moclobemide. | Addiction | 2003 | https://conductscience.org/library/papers/12603236 | PubMed |
| 7 | 12925718 | The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. | QJM | 2003 | https://conductscience.org/library/papers/12925718 | PubMed |
| 8 | 3308444 | Neuropeptide regulation of appetite and weight. | Endocr Rev | 1987 | https://conductscience.org/library/papers/3308444 | PubMed |
| 9 | 14520137 | Abnormal CSF monoamine metabolism in serotonin syndrome. | J Clin Psychopharmacol | 2003 | https://conductscience.org/library/papers/14520137 | PubMed |
| 10 | 17487226 | 5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats. | Neuropsychopharmacology | 2008 | https://conductscience.org/library/papers/17487226 | PubMed |
| 11 | 16230 | Blockade of 5-hydroxytryptamine receptors in the central nervous system by beta-adrenoceptor antagonists. | Neuropharmacology | 1977 | https://conductscience.org/library/papers/16230 | PubMed |
| 12 | 890205 | Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine. | Br J Pharmacol | 1977 | https://conductscience.org/library/papers/890205 | PubMed |
| 13 | 2902292 | Danger of MAOI therapy after fluoxetine withdrawal. | Lancet | 1988 | https://conductscience.org/library/papers/2902292 | PubMed |
| 14 | 16488409 | Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats. | Eur J Pharmacol | 2006 | https://conductscience.org/library/papers/16488409 | PubMed |
| 15 | 12504917 | Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours. | Neuropharmacology | 2002 | https://conductscience.org/library/papers/12504917 | PubMed |
| 16 | 3734795 | A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain. | J Neurochem | 1986 | https://conductscience.org/library/papers/3734795 | PubMed |
| 17 | 12649391 | Ambient temperature influences core body temperature response in rat lines bred for differences in sensitivity to 8-hydroxy-dipropylaminotetralin. | J Pharmacol Exp Ther | 2003 | https://conductscience.org/library/papers/12649391 | PubMed |
| 18 | 15743927 | 5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome. | J Pharmacol Exp Ther | 2005 | https://conductscience.org/library/papers/15743927 | PubMed |
| 19 | 9564630 | (R)(+)-N-propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B. | J Neural Transm Suppl | 1998 | https://conductscience.org/library/papers/9564630 | PubMed |
| 20 | 11127542 | Possible serotonin syndrome arising from an interaction between nortriptyline and selegiline in a lady with parkinsonism. | J Neurol | 2000 | https://conductscience.org/library/papers/11127542 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33799684 | Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33799684 | PubMed |
| 24067924 | Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats. | Neuropharmacology | 2014 | https://conductscience.org/library/papers/24067924 | PubMed |
| 19464285 | Assessment of 5-hydroxytryptamine efflux in rat brain during a mild, moderate and severe serotonin-toxicity syndrome. | Eur J Pharmacol | 2009 | https://conductscience.org/library/papers/19464285 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17823767
GET https://conductscience.org/api/papers/v1/17823767/references?page=2